What is Bausch Health Companies Inc. worth?
With the base-case assumptions below, a discounted cash flow model on Bausch Health Companies Inc.'s reported free cash flow gives $0.89 per share. The share price was $8.29 on November 10, 2026, 834% above that value.
Inputs from the filings
Three sets of assumptions
| Case | Growth yrs 1-5 | Discount rate | Value per share | Value vs price |
|---|---|---|---|---|
| Bear | 0.0% | 10.0% | -$17.97 | -317% |
| Base | 5.0% | 9.0% | $0.89 | -89% |
| Bull | 10.0% | 8.0% | $36.10 | +335% |
Sensitivity: base case value per share
| 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | |
|---|---|---|---|---|---|
| 7.0% | $14.38 | $18.49 | $23.51 | $29.79 | $37.85 |
| 8.0% | $4.32 | $6.99 | $10.13 | $13.91 | $18.53 |
| 9.0% | -$3.04 | -$1.21 | $0.89 | $3.34 | $6.24 |
| 10.0% | -$8.64 | -$7.35 | -$5.88 | -$4.20 | -$2.27 |
| 11.0% | -$13.06 | -$12.11 | -$11.05 | -$9.85 | -$8.50 |
Where the presets come from
Base: years 1 to 5 grow at Bausch Health Companies Inc.'s revenue growth rate over the last 5 fiscal years (5.0% a year), held between -5% and 15%. Years 6 to 10 grow halfway between that and the long-run rate of 2.5%. Future cash is discounted at 9% a year.
Bear: 5 points less growth, 2% long-run growth, 10% discount rate. Bull: 5 points more growth (at most 25%), 3% long-run growth, 8% discount rate.
Value per share = (present value of 10 years of free cash flow + present value of everything after + cash - debt) / diluted shares.
This is a model run on assumptions, not a recommendation or a price target. Small changes in the discount rate or growth move the result a lot, as the table above shows. Change them yourself in the calculator.
Adjust the assumptions
Move the sliders for growth, long-run growth and discount rate, or switch to average free cash flow, and see the value per share change.
Adjust the assumptions